key: cord-1005975-jqfvlox3
authors: Neto, João Araújo Barros; Mello, Carolina Santos; Vasconcelos, Sandra Mary Lima; Bádue, Gabriel Soares; Ferreira, Raphaela Costa; de Andrade, Maria Izabel Siqueira; Queirozdo Nascimento, Carlos; Macena, Mateus de Lima; da Silva, José Adailton; Clemente, Heleni Aires; Petribu, Marina de Moraes Vasconcelos; Dourado, Keila Fernandes; Pinho, Claudia Porto Sabino; Vieira, Renata Adrielle Lima; de Mello, Leilah Barbosa; Brandãodas Neves, Mariana; de Jesus, Camila Anjos; Palmeirados Santos, Tatiana Maria; Soares, Bruna Lúcia de Mendonça; Medeiros, Larissa de Brito; de França, Amanda Pereira; Sales, Ana Lina de Carvalho Cunha; Furtado, Elane Viana Hortegal; Oliveira, Alane Cabral; Farias, Fernanda Orrico; Freitas, Mariana Carvalho; Bueno, Nassib Bezerra
title: ASSOCIATION BETWEEN UNDERWEIGHT AND EXCESS BODY WEIGHT BEFORE SARS-COV-2 INFECTION AND CLINICAL OUTCOMES OF COVID-19: MULTICENTER STUDY
date: 2022-04-01
journal: Nutrition
DOI: 10.1016/j.nut.2022.111677
sha: bdc15c20896085e6b7aa44b7f382ff73982974f1
doc_id: 1005975
cord_uid: jqfvlox3

Background & aims The present study aimed to identify associations between extremes in body weight status (underweight and excess body weight) before COVID-19 diagnosis and clinical outcomes in patients infected with SARS-COV-2. Methods A multicenter cohort study was carried out in 8 different states in Northeastern Brazil. Demographic, clinical (previous diagnosis of comorbidities), and anthropometric (self-reported weight and height) data about individuals who tested positive for COVID-19 were collected. Outcomes included hospitalization, mechanical ventilation and death. Multivariable logistic regression models - adjusted based on age, sex and previous comorbidities – were used to assess the effects of extremes in body weight status on clinical outcomes. Results 1308 individuals were assessed (33.6% of them were elderly individuals). Univariable analyses showed that only hospitalization was more often observed among underweight (3.2 vs. 1.2%) and overweight (68.1 vs. 63.3%) individuals. Cardiovascular diseases, in turn, were more often observed in all clinical outcomes (hospitalization [19.7% vs. 4.8%]; mechanical ventilation [19.9% vs. 13.5%] and death [21.8% vs. 14.1%]). Based on the multivariable analysis, body weight status was not associated with risk of hospitalization (Underweight: OR: 1.10 [CI95%: 0.50; 2.41]; Excess body weight: 0.81 [0.57; 1.14]), mechanical ventilation (Underweight: 0.92 [0.52; 1.62]; Excess weight: 0.90 [0.67; 1.19]) and death (Underweight: 0.61 [0.31; 1.20]; Excess body weight: 0.88 [0.63; 1.23]). Conclusion Underweight and excess body weight were not independently associated with clinical outcomes in COVID-19 patients in the herein analyzed cohort; this finding indicates that the association between these variables may be confounded by both age and comorbidities.

The pandemic caused by the SARS-COV-2 viral infection currently plagues the world. Brazilwhich has significant territorial dimension and geographical differences, in addition to peculiar political issues associated with public health management has experienced a critical situation that exacerbated viral transmissibility. This factor resulted in hospital overcrowding in several states and compromised the quality of healthcare provided to affected individuals [1, 2] . Brazil ranked first in the number of new infected cases and deaths, worldwide, during the first half of 2021; the mortality rate in the country reached 2.5%. The Northeastern region -which is one of the poorest regions in the country and concentrates approximately 26% of the Brazilian populationaccounts for 10.7% and 10.4% of the total number of COVID-19 cases and deaths notified in Brazil, respectively [2] .

Overall, the first COVID-19 symptoms emerge after 5.2-day incubation; they can last 14 days, on average. These symptoms present great variability in time and clinical manifestations, which often affect the respiratory tract, among other organs and systems [3] . There is evidence that this disease shows higher prevalence among individuals with chronic non-communicable diseases (NCDs) such as diabetes, hypertension, respiratory diseases, cancer, among others [4] . Although there is no consensus in the literature, the extremes in body weight status -i.e., underweight and excessive body weight -can also be associated with morbidity and mortality rates resulting from SARS-COV-2 infection, regardless of the concomitant incidence of other associated comorbidities [5, 6] .

Although the effects of underweight on the clinical evolution of COVID-19 patients remains poorly explored, underweight prevalence in hospitalized patients is often high and leads to negative prognosis, since this condition is associated with longer hospitalization time, as well as with higher rehospitalization frequency and death rate [7, 8] . On the other hand, individuals with obesity appear to be more likely to evolve to the most severe form of this disease, to remain hospitalized for longer periods-of-time and to require respiratory support upon hospitalization [9, 10] .

It is important emphasizing that body mass index (BMI) is the anthropometric indicator most widely used to assess nutritional status in epidemiological and clinical studies. However, it is also important taking into consideration physiological and metabolic changes inherent to the aging process, since they have direct implications to the nutritional status and body composition of elderly individuals; thus, it is necessary using specific cutoff points for this population [11] . Nevertheless, several studies conducted with COVID-19 patients have used the same BMI cutoff point for both adult and elderly individuals; thus, they made the mistake of evaluating different groups as equals [12] [13] [14] .

Although there are references used to classify the nutritional status of each age group [15, 16] , the literature still lacks consensus about the most adequate BMI cutoff point to be adopted at the time to assess the nutritional status of elderly individuals; thus, classifying the nutritional status of individuals in this age group, based on BMI, enables comparing results in a given research to those deriving from other studies, as well as acknowledging that body changes observed in this population must be interpreted with caution.

History of unintentional weight loss before hospitalization is another nutritional status indicator that appears as independent factor for worse clinical prognoses and death in several pathological processes [17, 18] and that may be associated with nondiagnosed pre-existing diseases [19] . Moreover, it is associated with functional decline, frailty and higher risk of infections in the elderly population [20] ; therefore, it should be carefully investigated in patients with COVID-19.

It is important taking into consideration the likely association between previous underweight or excess body weight and worse clinical outcomes resulting from COVID-19 [5, 6] , and the peculiarities of Northeastern Brazil [1] , since this region presents high urban poverty levels [21] capable of influencing the epidemiological pattern seen in wealthier regions. Therefore, the aim of the current study was to investigate associations between underweight or excess body weight before COVID-19 diagnosis and clinical outcomes in patients infected with SARS-COV-2, in Northeastern Brazil.

Group in Northeastern Brazil (GENSCoV-BR). The study was coordinated by the 

The main study has followed a convenient sampling plan of non-probabilistic model by taking into consideration estimated mean prevalence of 20% obesity in adult individuals who live in the capitals of the Brazilian Northeastern states [22] ; margin of error was 2 %, confidence interval was 99%, and total sample comprised 2,647 individuals.

The investigated population comprised individuals treated for COVID-19, after laboratory diagnosis, based on protocols followed by partner healthcare services (i.e., public and private hospitals, emergency care units, basic health units, and flu-like syndrome units). The sample analyzed in the present study comprised 1,308 individuals, since many patients did not accept to participate in the study and had their decision respected. In addition, it is necessary highlighting the difficulty in collecting data during the daily routine of healthcare services (Figure 1 ). Antigen Test], who presented anthropometric data to establish their body weight status, who underwent hospital or home treatment for COVID-19, and who completed the follow-up until the cure or death outcomes, were included in the study. Patients with suspected COVID-19, whose diagnosis was not confirmed by at least one laboratory test, were not included in the study.

The herein included patients were identified and conveniently selected by health professionals from partner hospitals, by taking into consideration laboratory-based COVID-19 diagnosis inserted in their medical records; they were also identified through positive COVID-19 diagnosis, after attending emergency services -which are considered health system gateway entry -regardless of whether they were referred for hospitalization or home isolation.

After patients' identification, researchers have contacted them or their legal guardians by phone in order to invite them to voluntarily participate in the study. The ones who have agreed to participate in the study have electronically signed the informed consent form and completed the data collection form based on a guided interview.

Patients' information was also collected in their medical records, which are kept in the respective healthcare services they were assisted in.

Data deriving from medical records of hospitalized patients, or information on the health condition of patients undergoing home treatment, were collected both in a retrospective and prospective manner. Data deriving from medical records were collected up to the time of patients' hospital discharge or death. Patients undergoing home treatment were followed up in a remote manner -either by telephone contact or by virtual messaging application -until the end of the quarantine time (which corresponded to 21 days, in the current study) or symptoms relief, whichever took place last. Patients who needed hospitalization at some point, despite having started treatment at home, had their data collected from their medical records.

Demographic and clinical data about patients undergoing hospital or home treatment were collected. With respect to data collected through remote interview, variables were categorized into age [elderly in the age group ≥ 65 years (yes or no)]; sex (male or female), black skin color/race (yes or no), and unintentional weight loss report [regardless of the COVID-19 diagnosis (yes or no)]. Patients who reported having lost > 5% of its usual body weight in the previous 6 months was categorized as having unintentional weight loss, without any specific reason, such as advanced chronic diseases and their treatments, or known cause [23] . Information about the previous medical diagnosis of comorbidities, such as systemic arterial hypertension (SAH), diabetes mellitus (DM), cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma/other respiratory diseases, was also collected.

The incidence of the following clinical events was assessed based on data obtained in healthcare service records: need of hospitalization due to COVID-19 (yes or no), need of mechanical ventilation during treatment (yes or no) and death (yes or no).

As for anthropometric data, information on current self-reported height and weight was used to calculate patients' body mass index (BMI).

Participants' BMI was herein classified in two different ways. First, BMI was categorized based on standards recommended by the World Health Organization (WHO) [15] , for adults; and by Lipschitz [16] , for elderly individuals. It was done to unify the nutritional status analysis between adult and elderly individuals, by respecting changes in body composition inherent to the aging process. Thus, adult individuals with BMI > 25.0 kg/m² and elderly individuals with BMI > 27.0 kg/m² were classified as having excessive body weight. Accordingly, adult individuals with BMI < 18.5 kg/m² and elderly individuals with BMI < 22.0 kg/m² were classified as underweight. Second, since Lipschitz's classification does not establish cut-off point for overweight and obesity, and to enable comparing data from the current research to those of other studies, all participants were also classified according to standards established by WHO (regardless of their age), namely: overweight (BMI > 25.0 and < 29.9); and obese (BMI  30.0 kg/m²).

The Statistical Package for Social Sciences (SPSS) software, version 21.0 (IBM Inc, Chicago, IL, USA), was used for statistical analysis, which adopted alpha value equal to 5%. Absolute and relative frequencies were calculated for categorical variables.

Chi-square test (χ2) or Fisher's exact test was applied to check univariable association between categorical variables, depending on the expected frequency of counts for each cell. Multivariable binary logistic model, adjusted based on age, sex, color/race, Federative unit, as well as on the diagnosis of SAH, DM, CVD, COPD and asthma/other respiratory diseases, was used to calculate the adjusted odds ratio (OR) between BMI categories presenting any of the investigated outcomes (hospitalization, mechanical ventilation, and/or death). BMI categories were always included as independent variable in the adopted models; "normal weight" was used as reference category. Unintentional weight loss was also included as independent variable. To further explore the associations between BMI category and clinical outcomes, and the possible modification effects of age category (< 65 years or >65 years old) in this relationship (between BMI categories and clinical outcomes), interaction analysis were conducted. In this analysis, the full multivariable model further received an interaction term "age_group*BMI_category", to be possible to assess if the effects of BMI categories in the clinical outcomes differed between the two age groups. If the interaction term showed a significant p-value, evidence of modification of effects was considered.

In total, 439 (33.6%) of the 1308 evaluated patients were elderly individuals, Sociodemographic, clinical and anthropometric features of patients included in the current study are described in Table 1 .

Based on the univariable analysis, age ≥ 65 years, male sex, black color/race, incidence of SAH, DM, CVD, COPD, asthma/other respiratory diseases, BMI categories, obesity and unintentional weight loss were associated with the need of hospitalization. Variables such as age ≥ 65 years, male sex, DM, CVD and asthma or other respiratory disease have shown significant association with the need of mechanical ventilation. Age ≥ 65, male sex, SAH, CVD and asthma, or other respiratory diseases, were significantly associated with outcome "death". Previous COPD diagnosis was more often recorded among patients who required hospitalization, whereas previous asthma diagnosis was negatively associated with events such as hospitalization, mechanical ventilation and death. In addition, unintentional weight loss was more often observed for the group of patients who required hospitalization, although it was not associated with mechanical ventilation or death ( Table 2) .

Underweight was more often observed among patients who required hospitalization, when the BMI of adult and elderly individuals was classified based on cutoff points established by WHO (1995) [13] and Lipschitz (1994) [14] , respectively.

On the other hand, excess body weight was more frequent among patients who underwent home treatment and successfully healed ( Table 2) . However, based on the classification by WHO (1995) [13] , none of the assessed patients presented association between BMI categories and hospitalization, regardless of age.

Multivariable analysis was carried out to identify association of BMI categories, obesity diagnosis, and history of unintentional weight loss with the investigated clinical events, adjusted based on sex, age and other risk factors. Based on this analysis, neither the BMI categories nor the history of unintentional weight loss were associated with risk of hospitalization, mechanical ventilation and death ( Table 3) 

The aim of the current research was to investigate whether underweight and excess body weight were associated with clinical complications of COVID-19 in Northeastern Brazil. Based on the univariable analyses, only hospitalization was associated with BMI categories, obesity and unintentional weight loss (featured by loss > 5% of usual body weight in the previous 6 months, without intention or apparent reason). Nevertheless, multivariable analysis has indicated that none of the BMI categories were risk factors for hospitalization, mechanical ventilation or death. Therefore, the gross effect of body weight status on clinical complications caused by COVID-19 in this sample was confounded by both age and other known risk factors, such as NCDs.

With respect to the univariable association between underweight and hospitalization, although the link between malnutrition (either acute or chronic) and infection is quite complex, it has been repeatedly corroborated and has long been acknowledged by WHO [24, 25] . Previous evidence highlighted in other pathological processes have pointed out that underweight impairs patients' immune function, mainly their cell-mediated immunity, a fact that turns underweight individuals in a group at higher risk of evolving towards adverse results and of presenting the worst prognosis [26] . Few studies have shown the effect of underweight on negative COVID-19

outcomes. According to Kim et al (2020) , underweight patients were at higher risk of presenting outcomes such as mechanical ventilation and death, after adjusting based on age, sex, race/ethnicity, incidence of comorbidities, smoking habit and hospital type [27] . It is worth emphasizing that underweight is just one of the malnutrition indicators used for adult individuals. Most recently, a meta-analysis comprising studies that used nutritional risk screening tools among hospitalized patients with COVID-19 has pointed towards increased risk of death in patients at risk of malnutrition [28] . This finding can be explained by patients' increased resting energy expenditure, reduced oral intake [28, 29] and impaired immune system [30] .

Based on the current results, excess body weight has only shown association with hospitalization in the univariable analysis. The frequency of excess body weight in COVID-19 patients was similar to that observed for the rest of the population living in the capitals of Northeastern Brazil states, which ranged from 50.3% to 59.5%, according to data deriving from the largest population survey focused on identifying risk and protective factors for chronic diseases in Brazil [22] . The highest frequency of individuals with excess body weight was herein observed among those who remained in isolation at home and who did not require hospitalization. This finding diverges from most publications on this topic. It is important emphasizing that some studies that have identified excess body weight as risk factor for clinical outcomes of COVID-19 have disregarded the preexistence of NCDs, which comprise well-known risk factors such as DM, SAH, chronic kidney disease, and that can be primary or secondary to overweight [6, 31] . The aforementioned studies included almost exclusively hospitalized or critically-ill patients in their samples, and they disregarded the prevalence of excess body weight in patients affected by the mild form of COVID-19, who did not require hospitalization [27, 32] . Some studies have even used WHO's criteria (BMI > 25kg/m²) [15] as cut-off points to classify overweight in elderly individuals. They also overestimated the prevalence of overweight/obesity in this age group, which accounts for most patients hospitalized due to COVID-19 [6, 27, 32] Studies that only focus on assessing hospitalized individuals (rather than individuals treated both at home and at the hospital) and, according to which, obesity is associated with worse outcomes, may present some collider bias type, in which the single condition "hospitalized" may induce confounding associations between obesity and death, since the incidence of pre-existing chronic diseases (closely associated with obesity and age) can favor the most severe forms of COVID-19 and lead to hospitalizations [33] . Limiting the sample to individuals who experienced events such as hospitalization, and disregarding the fact that variable "obesity" is directly influenced by the other two variables (NCDs and age), lead to colliding bias in many studies about COVID-19, as well as induce results and distort the real associations between these variables in the assessed sample [34] .

In addition, it is noteworthy that results presented in most of these studies contrast to the "obesity paradox" in critically-ill patients; according to this paradox, patients with higher weight could have better metabolic reserve to tolerate a given inflammatory condition due to high catabolism, as observed for pneumonia caused by SARS-CoV-2 infection, this being protective factor regarding mortality when adjusted by classical risk factors [33] . Interestingly, no association pattern has emerged when the association between obesity and clinical outcomes in the herein investigated sample was adjusted based on regular risk factors (NCDs). This finding has indicated total lack of association between obesity and clinical outcomes in the current sample, neither in the univariable analysis, nor in the adjusted one. Different findings arising from different cutoff points established to classify body weight status based on the BMI of adult and elderly individuals were another relevant aspect observed in the current study. BMI presented good correlation to morbidity and mortality rates when cutoff points specific to age were taken into consideration [35] . It happened because metabolic and body composition-related changes inherent to the aging process require the adoption of specific cutoff points for this population, mainly if one aims at predicting death associated with excess body weight. The present study has disregarded the existence of specific and consolidated cut-off points set for the elderly population, and applied WHO's criteria [15] to all individuals; consequently, there was increased overweight/obesity prevalence in the analyzed sample. This factor may have induced observers to overestimate this variable as risk factor for COVID-19 complications in hospitalized patients.

On the other hand, adipose tissue accumulation in the abdominal region triggers mild inflammatory processes, increases angiotensin-converting enzyme 2 expression by adipocytes and hyperactivates the renin-angiotensin system, which leads to endothelial dysfunction. These factors may contribute to worsen the disease and to the emergence of symptoms in patients with COVID-19, mainly when they are associated with other pre-existing risk factors (such as age, NCDs, and immunodeficiency) capable of contributing to the most severe forms of this disease [36] [37] [38] .

Unintentional weight loss in the current study was more often observed in patients who needed hospitalization throughout the disease, although this association was not significant in the adjusted analysis. Previous evidence has shown that patients infected with SARS-COV-2 often experience acute malnutrition scenario days before hospitalization [39] , mainly the most severe cases; inflammatory storm and inevitable trend towards weight loss were also reported [40] . Moreover, the incidence of preexisting chronic diseases can contribute to nutritional impairment [40] . It is worth emphasizing that the angiotensin-converting enzyme 2 is also found in skeletal muscle, a fact that leads individuals with COVID-19 to have myalgia and muscle loss [41] . Data capable of explaining the role played by ACE-2 in inducing weight loss during COVID-19 remain scarce; however, it is well-known that its main function lies on regulating the renin-angiotensin system, which leads to vasoconstriction, increased sodium absorption and inflammation, as well as contributes to patients' hyperinflammatory and catabolic state. In addition, ACE-2 overexpression appears to increase myocellular and adipose insulin sensitivity and to favor weight loss [42] . Furthermore, the acute malnutrition condition observed in patients with COVID-19 infection [28, 39] leads to adipose tissue mobilization, due to lipolysis induced by increased adiponectin and decreased leptin secretion [43] . Patients' inflammatory state induces the release of cortisol and adrenergic hormones, which can also lead to increased fat oxidation and decreased adipose tissue rates [44] .

The method used to collect weight and height data used to calculate patients' BMIi.e., self-reported information -, and the use of this indicator as the only marker of nutritional status, were important limitations of the current study. The self-report strategy was herein adopted for anthropometric assessment purposes in order to avoid physical contact with patients infected with COVID-19, as well as to avoid the use of the same assessment instrument by several patients and to enable collecting data about several patients who were unable to walk to the assessment equipment (scale and stadiometer) due to disease worsening. Thus, although the number of assessed patients has increased, it was possible mitigating the likelihood of contamination by health professionals and ruling out the risk of spreading SARS-COV-2, a practice recommended by international guidelines [45, 46] . It is important emphasizing that, in addition to the aforementioned reasons for using the selected method, the direct measurement of these variables and other body composition measurements could not be performed during the peak of the COVID-19 pandemic in Brazil due to health professionals' workload and to the need of restricting physical contact and implementing airborne precautions in hospital environments. Despite these limitations, these measurements are validated and used to assess nutritional status in national and international epidemiological and clinical studies [47] [48] [49] [50] [51] . In addition, they provided the study with a more homogeneous nutritional status assessment among all research centers, based on using scientific techniques and procedures; they took into consideration the reality and routine of healthcare services in the COVID-19 pandemic context. However, measurement information self-reported by patients with COVID-19 should be used with caution, since these patients present heterogeneous features, such as age. Hence, self-reported body weight may not be efficient in reflecting the current weight of these patients. On the other hand, although BMI is an important indicator of body weight status, it does not differentiate body compartments (muscle and adipose reserve) or reflect fat distribution in the human bodyit is more sensitive in association with other anthropometric measurements capable of evaluating body composition [52, 53] . Yet, this assessment tool may be more valid than the use of medical records in healthcare systems, which do not indicate the adopted method. Thus, different measurement methods may be used in the same study, such as visual observation performed by untrained health professionals.

Other limitations worth to be highlighted are lack of individual socioeconomic information about patients and the adoption of convenience sampling method in a study carried out in one of the poorest regions in Brazil -which experiences unfavorable socioeconomic and political context. However, it is noteworthy that obtaining individual socioeconomic data capable of accurately reflecting the economic conditions individuals live in, requires adopting extensive data collection protocols that can be considered invasive and uncomfortable. Although these protocols were described in the data collection protocol of the current study, they were not completed by most participants, mainly by the most severe cases. Thus, participants' socioeconomic condition was not taken into consideration in the current study to ensure satisfactory sample size and the quality of the herein performed analyses, as well as to give strength and reliability to the assessed data. It is important emphasizing that, although the sampling plan was featured as of the convenience type, the sample distribution proportionality among the collaborating centers was respected and different health services were included in it, in order to recruit patients from different social strata, with different intensities of COVID-19, either hospitalized or treated at home.

It was possible concluding that BMI categories, obesity and unintentional weight loss, observed in the herein assessed sample, were overall associated with COVID-19 patients' hospitalization. Based on the adjusted analysis, underweight, excess body weight and obesity were not independently associated with clinical outcomes in these patients. This finding indicated that the association among these variables was confounded by both age and traditional risk factors, such as NCDs.

None. 

COVID-19 in Brazil: the headlines should be about science

Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Analysis of mortality and morbidity in COVID-19 patients with obesity using clinical epidemiological data from the Korean Center for Disease Control & Prevention

Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data

Nutritional risk screening and body composition in COVID-19 patients hospitalized in an internal medicine ward

Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: an overview

Body mass index and risk for intubation or death in SARS-CoV-2 Infection: A retrospective cohort study

Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding

Avaliação antropométrica em idosos: estimativas de peso e altura e concordância entre classificações de IMC

High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation

Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

World Health Organization (1995) Physical status: the use and interpretation of anthropometry

Screening for nutritional status in the elderly

Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis

The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis

Unintentional weight loss: Clinical characteristics and outcomes in a prospective cohort of 2677 patients

Unintentional weight loss in older adults

COVID-19 in Northeast Brazil: achievements and limitations in the responses of the state governments

Vigitel Brasil 2019: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. Brasília

Involuntary weight loss

Malnutrition and infection: complex mechanisms and global impacts

Nutrition status affects COVID-19 patient outcomes

Feeding the immune system

Body mass index as a risk factor for clinical outcomes in patients hospitalized with COVID-19 in New York

Kabthymer RH (2021) Prevalence and outcomes of malnutrition among hospitalized COVID-19 patients: A systematic review and meta-analysis

Anthropometric assessment in ambulatory nutrition amid the COVID-19 pandemic: Possibilities for the remote and in-person care

Nutritional imbalances and infections affect the thymus: Consequences on T-cell-mediated immune responses

Diseases and disorders associated with excess body weight

The association between body mass index class and coronavirus disease 2019 outcomes

Collider bias is only a partial explanation for the obesity paradox

Collider bias undermines our understanding of COVID-19 disease risk and severity

Body-mass index and all-cause mortality: individual-participant-data-meta-analysis of 239 prospective studies in four continents

Obesity and outcomes in COVID-19: when an epidemic and pandemic collide

Hypercoagulopathy and adipose tissue exacerbated inflammation may explain higher mortality in COVID-19 patients with obesity

Overweight and obesity are risk factors for Coronavirus Disease 2019: A propensity score-matched case-control study

Evaluation of nutrition risk and its association with mortality risk in severely and critically ill COVID-19 patients

Clinical significance of nutritional risk screening for older adult patients with COVID-19

COVID-19: a major cause of cachexia and sarcopenia? J Cachexia

Metabolic impact of weight loss induced reduction of adipose ACE-2-potential implication in COVID-19 infections

Different modulation by dietary restriction of adipokine expression in white adipose tissue sites in the rat

Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options -a mini-review

Nutritional therapy in hospital care of in-patients with Covid-19: evidence, consensus and practice guidelines

ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection

COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: a post-hoc analysis of a prospective cohort study

Validade da massa corporal e da estatura autorreferidas: relações com sexo, idade, atividade física e fatores de risco cardiometabólicos

Saúde cardiovascular e validação do escore autorreferido no Brasil: uma análise da Pesquisa Nacional de Saúde

Estimation of body mass index from self-reported measures: what is the validity?

Validity of self-reported height and weight and derived body mass index in middle-aged and elderly individuals in Australia

Accuracy of self-reported height, weight, and BMI over time in emerging adults

Self-reported vs. measured height, weight and BMI in young adults